1. Introduction {#s0005}
===============

The current outbreak of coronavirus disease (COVID-19) that was first reported from Wuhan, China, in December 2019. This epidemic had spread to 206 countries and territories around the world and 2 international conveyances with 1,203,459 confirmed cases, including 64,754 deaths, as of April 05, 2020, so the World Health Organization declared it as a Public Health Emergency of worldwide (<https://www.worldometers.info/coronavirus/>). Similarly, Middle East respiratory syndrome coronavirus (MERS-CoV) had become a worldwide health concern. MERS-CoV originally reported in 2012 ([@bb0020]). It affected more than 2000 people in 27 countries and 4 sub-continents in the Middle East. While the epidemic of SARS affected 26 countries and resulted in more than 8000 cases in 2003 ([@bb0020]). Since then, a small number of cases have occurred as a result of laboratory accidents or, possibly, through animal-to-human transmission (Guangdong, China) ([@bb0020]).

This study analyzed and discussed available published genome until April 05, 2020, for a better understanding of the genomic variation and characterization of a novel coronavirus (COVID-19). This virus is transmitted from person to person via droplet transmission ([@bb0060]; [@bb2000]). Therefore, the virus is spreading easily in overcrowded areas. Most patients experience only mild to moderate symptoms, such as high body temperature in conjunction with some respiratory symptoms such as cough, sore throat, and headache. Some people may have severe symptoms like pneumonia and acute respiratory distress syndrome ([@bb0015]). Also, individuals with underlying complications such as heart disease, chronic lung disease, or diabetes potentially display more severe symptoms ([@bb0005]). Preventive measures such as masks, frequent hand washing, staying home when sick, avoid public contact, and quarantines are being recommended for reducing the transmission. To date, no specific antiviral treatment is proven effective, hence, infected people initially rely on symptomatic treatments that showed encouraging profile for blocking the new coronavirus in early clinical trials.

Importantly, the genome size of the SARS-CoV-2 varies from 29.8 kb to 29.9 kb and its genome structure followed the specific gene characteristics to known CoVs; the 5′ more than two-thirds of the genome comprises orf1ab encoding orf1abpolyproteins, while the 3′ one third consists of genes encoding structural proteins including surface (S), envelope (E), membrane (M), and nucleocapsid N proteins ([Fig. 1](#f0005){ref-type="fig"} ). Additionally, the SARS-CoV-2 contains 6 accessory proteins, encoded by ORF3a, ORF6, ORF7a, ORF7b, and ORF8 genes ([Fig. 1](#f0005){ref-type="fig"}) ([@bb0055]; [@bb0080]).Fig. 1Structure of the SARS-CoV-2 genome.Fig. 1

Recently, the development of high-throughput sequencing has provided datasets of high-quality, complete genome sequences for viral isolates collected in a relatively unbiased manner, regardless of virulence or other unusual characteristics. Analyses of the genome sequence data combined with large-scale antigenic typing have given insights into the pattern of global spread, the genetic diversity during seasonal epidemics, and the dynamics of subtype evolution. SARS-CoV-2 such as the NCBI Severe acute respiratory syndrome coronavirus 2 database (<http://www.nhc.gov.cn/jkj/s7915/202001/e4e2d5e6f01147e0a8df3f6701d49f33.shtml>) and NGDC Genome Warehouse ([bigd.big.ac.cn/gwh/](http://bigd.big.ac.cn/gwh/){#ir0015}) make the genomic information publicly available, together with epidemiological data for the sequenced isolates. The data sharing requires users to agree to collaborate with, and appropriately credit, all data contributors. A notable success of this initiative has been the contribution of countries, such as China, Philippines, and Japan, etc. which have previously been reticent about placing data in the public domain. The WHO also supports the endeavor of rapid publication of all available sequences for coronaviruses and there is hope that comprehensive submission to public databases will soon become a reality.

The finding heavily supports an intense requirement for additional prompt, inclusive investigations that combine genomic detail, epidemiological information and graph records of the clinical features of patients with COVID-19 ([@bb0085]). In the future, mining these resources and establishing a statistical framework based on epidemiological, antigenic, and genetic information could provide further insights into the rules that govern the emergence and establishment of antigenically novel variants and improve the potential for SARS-CoV-2 prevention and control ([@bb0025]; [@bb0115]). In this study, we investigated the extent of molecular variation between the recently sequenced genomes of SARS-CoV-2.

2. Methodology {#s0010}
==============

We have downloaded 94 publicly available genomes from Genbank up to 12 March. Among 94 genomes, some of the genomes were not used for the analysis due to unusually high variants with gaps. NC_045512 genome sequence was used for reference and the genomic coordinate in this study is based on this reference genome ([@bb0065]). Therefore, genomic coordinates must be adjusted to compare with previous studies ([@bb0050])

Each genome was first aligned to NC_045512 using the EMBOSS needle with a default gap penalty of 10 and an extension penalty of 0.5. Then, differences in comparison with NC_045512 were extracted to create variants ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"} ) ([@bb0090]). Based on protein annotations, nucleotide level variants were converted into amino acid codon variants for alignments when its location within a gene was identified ([@bb0010]). Nucleotide mutations in the genomes were revealed.Table 1Coding mutation list detected in SARS-CoV-2 genomes.Table 1AccessionLocation-dateNucleotide variationGeneAmino acid changeMutation typeMT24047904-03-2020/Pakistan\
Gilgit1 1497G\>AOrf1abSynonymous mutationMN99652730/Dec/2019-China\
Wuhan21316G\>AOrf1abD7018NMissenseMN99652730/Dec/2019-China\
Wuhan24292A\>GSSynonymous mutationLC52823210/Feb/2020-Japan11083T\>GOrf1abL3606FMissenseLC52823210/Feb/2020-Japan29642C\>TORF10Synonymous mutationLR75799505/Jan/2020-China\
Wuhan28144T\>CORF8L84SMissenseLR75799812/26/2019-China\
Wuhan6968C\>AOrf1abL2235IMissenseLR75799812/26/2019-China\
Wuhan11749T\>AOrf1abSynonymous mutationMN9383841/10/2020-China\
Shenzhen8782C\>TOrf1abSynonymous mutationMN9383841/10/2020-China\
Shenzhen28144T\>CORF8L84SMissenseMN9383841/10/2020-China\
Shenzhen29095C\>TNSynonymous mutationMN97526211/Jan/2020-China8782C\>TOrf1abSynonymous mutationMN97526211/Jan/2020-China9534C\>TOrf1abT3090IMissenseMN97526211/Jan/2020-China29095C\>TNSynonymous mutationMN97526211/Jan/2020-China28144T\>CORF8L84SMissenseMN97526211/Jan/2020-China8782C\>TOrf1abSynonymous mutationMN98532519/Jan/2020-USA\
WA28144T\>CORF8L84SMissenseMN99446723/Jan/2020-USA\
CA1548G\>AOrf1abS428NMissenseMN99446723/Jan/2020-USA\
CA8782C\>TOrf1abSynonymous mutationMN99446723/Jan/2020-USA\
CA26729T\>CMSynonymous mutationMN99446723/Jan/2020-USA\
CA28077G\>CORF8V62LMissenseMN99446723/Jan/2020-USA\
CA28144T\>CORF8L84SMissenseMN99446723/Jan/2020-USA\
CA28792A\>CNSynonymous mutationMN99446723/Jan/2020-USA\
CA1912C\>TOrf1abSynonymous mutationGWHABKF0000000123/Dec/2019-China\
Wuhan3778A\>GOrf1abSynonymous mutationGWHABKF0000000123/Dec/2019-China\
Wuhan8388A\>GOrf1abN2708SMissenseGWHABKF0000000123/Dec/2019-China\
Wuhan8987T\>AOrf1abF2908IMissenseGWHABKK0000000130/Dec/2019-China\
Wuhan24325A\>GSSynonymous mutationGWHABKK0000000130/Dec/2019-China\
Wuhan21316G\>AOrf1abD7018NMissenseGWHABKH0000000130/Dec/2019-China\
Wuhan6996T\>COrf1abI2244TMissenseGWHABKJ0000000101/Jan/2019-China\
Wuhan7866G\>TOrf1abG2534VMissenseGWHABKM0000000130/Dec/2019-China\
Wuhan21137A\>GOrf1abK6958RMissenseGWHABKM0000000130/Dec/2019-China\
Wuhan7016G\>AOrf1abG2251SMissenseGWHABKO0000000130/Dec/2019-China\
Wuhan8001A\>COrf1abD2579AMissenseGWHABKO0000000130/Dec/2019-China\
Wuhan9534C\>TOrf1abT3090IMissenseMT18834105/Mar/2020-USA\
MN6035A\>GOrf1abSynonymous mutationMT18834105/Mar/2020-USA\
MN8782C\>TOrf1abSynonymous mutationMT18834105/Mar/2020-USA\
MN16467A\>GOrf1abSynonymous mutationMT18834105/Mar/2020-USA\
MN18060C\>TOrf1abSynonymous mutationMT18834105/Mar/2020-USA\
MN21386insTOrf1abInsertionMT18834105/Mar/2020-USA\
MN21388-21390insTTOrf1abInsertionMT18834105/Mar/2020-USA\
MN23185C\>TSSynonymous mutationMT18834105/Mar/2020-USA\
MN28144T\>CORF8L84SMissenseMT18833909/Mar/2020-USA\
MN8782C\>TOrf1abSynonymous mutationMT18833909/Mar/2020-USA\
MN17423A\>GOrf1abY5720CMissenseMT18833909/Mar/2020-USA\
MN18060C\>TOrf1abSynonymous mutationMT18833909/Mar/2020-USA\
MN21386C\>TOrf1abSynonymous mutationMT18833909/Mar/2020-USA\
MN22432C\>TSSynonymous mutationMT18833909/Mar/2020-USA\
MN28144T\>CORF8L84SMissenseMT12121502/Feb/2020-China\
Shanghai6031C\>TOrf1abSynonymous mutationMT12329005/Feb/2020-China\
Guangzhou15597T\>COrf1abSynonymous mutationMT12329005/Feb/2020-China\
Guangzhou29095C\>TNSynonymous mutationMT1268082/28/2020-Brazil26144G\>TORF3aG251VMissenseMT06617531/Jan/2020-Taiwan8782C\>TOrf1abSynonymous mutationMT06617531/Jan/2020-Taiwan28144T\>CORF8L84SMissenseMT09357107/Feb/2020-Sweden13225C\>GOrf1abSynonymous mutationMT09357107/Feb/2020-Sweden13226T\>COrf1abSynonymous mutationMT09357107/Feb/2020-Sweden17423A\>GOrf1abY5720CMissenseMT09357107/Feb/2020-Sweden23952T\>GSSynonymous mutationMT06615630/Jan/2020-Italy11083T\>GOrf1abL3606FMissenseMT06615630/Jan/2020-Italy26144G\>TORF3aG251VMissenseLC52297520/JAN/2020-JAPAN8782C\>TOrf1abSynonymous mutationLC52297520/JAN/2020-JAPAN29095C\>TNSynonymous mutationLC52297520/JAN/2020-JAPAN28144T\>CORF8L84SMissenseLC52297520/JAN/2020-JAPAN2662C\>TORF1abSynonymous mutationLC52297420/JAN/2020-JAPAN8782C\>TORF1abSynonymous mutationLC52297420/JAN/2020-JAPAN29095C\>TNSynonymous mutationLC52297420/JAN/2020-JAPAN28144T\>CORF8L84SMissenseLC52297420/JAN/2020-JAPAN2662C\>TORF1abSynonymous mutationLC52297320/JAN/2020-JAPAN8782C\>TORF1abSynonymous mutationLC52297320/JAN/2020-JAPAN29095C\>TNSynonymous mutationLC52297320/JAN/2020-JAPAN3792C\>TORF1abA1176VMissenseLC52297320/JAN/2020-JAPAN29095C\>TNSynonymous mutationLC52297320/JAN/2020-JAPAN2662C\>TORF1abSynonymous mutationLC52297320/JAN/2020-JAPAN28144T\>CORF8L84SMissenseLC52297220/JAN/2020-JAPAN29303C\>TNP344SMissenseLC52297220/JAN/2020-JAPAN25810C\>GORF3aL140VMissenseLC52297220/JAN/2020-JAPAN11557G\>TORF1abE3764DMissenseLC52297220/JAN/2020-JAPAN15324C\>TORF1abSynonymous mutationLC52192521/JAN/2020-JAPAN1912C\>TORF1abSynonymous mutationLC52192521/JAN/2020-JAPAN18512C\>TORF1abP6083LMissenseLC52192521/JAN/2020-JAPAN359_382delORF1abG32_L39delDeletionMN98871321/JAN/2020-USA\
Chicago24034C\>TSSynonymous mutationMN98871321/JAN/2020-USA\
Chicago26729T\>CMSynonymous mutationMN98871321/JAN/2020-USA\
Chicago8782C\>TORF1abSynonymous mutationMN98871321/JAN/2020-USA\
Chicago490T\>AORF1abD75EMissenseMN98871321/JAN/2020-USA\
Chicago3177C\>TORF1abP971LMissenseMN98871321/JAN/2020-USA\
Chicago28854C\>TNS194LMissenseMN98871321/JAN/2020-USA\
Chicago28077G\>CORF8V62LMissenseMN98871321/JAN/2020-USA\
Chicago28144T\>CORF8L84SMissenseMN99740921/JAN/2020-USA\
Arizona8782C\>TORF1abSynonymous mutationMN99740921/JAN/2020-USA\
Arizona29095C\>TNSynonymous mutationMN99740921/JAN/2020-USA\
Arizona11083G\>TORF1abL3606FMissenseMN99740921/JAN/2020-USA\
Arizona28144T\>CORF8L84SMissenseMT07268826/JAN/2020-USA: Massachussetts24034C\>TSSynonymous mutationNMDC60013002-0901/JAN/2019-China\
Wuhan27493C\>TORF7aP34SMissenseNMDC60013002-0901/JAN/2019-China\
Wuhan28253C\>TORF8Synonymous mutationNMDC60013002-1030/Dec/2019-China\
Wuhan20679G\>AORF1abSynonymous mutationNMDC60013002-0130/Dec/2019-China\
Wuhan11764T\>AORF1abN3833KMissenseNMDC60013002-0630/Dec/2019-China\
Wuhan24325A\>GSSynonymous mutationNMDC60013002-0405/Dec/2019-China\
Wuhan28144T\>CORF8L84SMissenseTable 2Non-coding mutation list detected in SARS-CoV-2 genomes.Table 2AccessionLocation-dateNucleotide variationUTR typeMT24047904-03-2020/Pakistan\
Gilgit241C\>T5 UTRMT12329005/Feb/2020-China\
Guangzhou4A\>T5 UTRMT00754425/Jan/2020-Australia\
Victoria29749-29759del3 UTRNMDC60013002-0707/JAN/2019-China\
Wuhan29869del3 UTRNMDC60013002-0405/Dec/2019-China\
Wuhan29856T\>A3 UTRNMDC60013002-0405/Dec/2019-China\
Wuhan29854C\>T3 UTRNMDC60013002-0405/Dec/2019-China\
Wuhan16C\>T5 UTRMT04995117/Jan/2019-China\
Yunnan75C\>A5 UTRLC52297520/JAN/2020-JAPAN29705G\>T3 UTRGWHABKG0000000130/Dec/2019-China\
Wuhan124G\>A5 UTRGWHABKG0000000130/Dec/2019-China\
Wuhan120T\>C5 UTRGWHABKG0000000130/Dec/2019-China\
Wuhan119C\>G5 UTRGWHABKG0000000130/Dec/2019-China\
Wuhan112T\>G5 UTRGWHABKG0000000130/Dec/2019-China\
Wuhan111T\>C5 UTRGWHABKG0000000130/Dec/2019-China\
Wuhan104T\>A5 UTR

3. Results {#s0015}
==========

A hundred fifty-six total variants were found and 116 unique variants as shown in [Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}. Among the 95 genomes we analyzed, 24 samples did not exhibit any variants except for missing starts and end base pairs. The distinct variants consist of 46 missense, 52 synonymous, 2 insertion, 1 deletion and 14 non-coding alleles in [Fig. 1](#f0005){ref-type="fig"}. The most common variants were 8782C\>T(ORF1ab) in 13 samples, 28144T\>C (ORF8) in 14 samples and 29095C\>T (N) in 8samples. The occurrences of 8782C\>T and 28144T\>C coincide. 29095C\>T is found in the subset of them. Both 8782C\>T and 29095C\>T are synonymous; however, 28144T\>C causes amino acid to change L84S in ORF8. Notably, most of 8782C\>T and 28144T\>Cvariant substrains are found outside of Wuhan. For the 46 missense variants, 24 variants are found in ORF1ab, which is the longest ORF occupying 2/3 of the entire genome. ORF1ab is cleaved into many nonstructural proteins (NSP1-NSP16). Among NSP\'s, NSP3 has more variants in the analyzed samples. All noncoding mutations are located in 5′ UTR or 3′ UTR regions. In terms of base changes, the most frequently observed one is C\>T as shown in [Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}.

4. Discussion {#s0020}
=============

The genetic information of any life is protected in its genome, and annotation is the initial step to interpret the sequence. The length of the SARS-CoV genome is over 30 Kb, while just a few coding genes appear not to accord with the general properties for the viral genome and the minimum grouping of hereditary data. In addition to these, it may have some non-structural proteins but lacking data at one place is needed. The absence probably results from their short existing-time before decomposition. In this study, we worked to find the extent of molecular variation between the recently sequenced genomes of SARS-CoV-2.

Numerous investigations have depicted that ORFs and ACE2 genes play a key role during novel coronavirus disease ([@bb0050]; [@bb0045]; [@bb0105]; [@bb0110]). So in our study, 156 total variants were found and 116 unique variants ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}). Among the 95 genomes we analyzed, 24 samples did not exhibit any variants except for missing starts and end base pairs. Additionally, the distinct variants consist of 46 missense, 52 synonymous, 2 insertions, 1 deletion, 14 non-coding alleles ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}). Most common variants were 8782C\>T(ORF1ab) in 13 samples, 28144T\>C (ORF8) in 14 samples and 29095C\>T (N) in 8 samples.The occurrences of 8782C\>T and 28144T\>C coincide. 29095C\>T is found in the subset of them. Both 8782C\>T and 29095C\>T are synonymous; however, 28144T\>C causes amino acid to change L84S in ORF8. It is notable that most of 8782C\>T and 28144T\>C variant substrains are found outside of Wuhan. For the 46 missense variants, 24 variants are found in ORF1ab, which is the longest ORF occupying 2/3 of the entire genome. ORF1ab is cleaved into many nonstructural proteins (NSP1-NSP16). Among NSP\'s, NSP3 has more variants in the analyzed samples. All noncoding mutations are located in 3′UTR or 5′UTR. In terms of base changes, the most frequently observed one is C\>T ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}).

The replicase enzyme is displayed as two polyproteins (ORF1a and ORF1ab), which are prepared into 12 nonstructural proteins by three viral proteases ([@bb0105]). This ORF1ab polyprotein includes the nsps 1--3 proteins. This area of ORF1ab is the most important factor among coronaviruses ([@bb0110]). Many researchers found the relationship between ORFs with COVID-19 i.e.8782C\>T(ORF1ab) and 28144T\>C (ORF8) are available among genomic databases ([@bb0045]; [@bb0050]). Hence, it will be clinically significant to break down the biological function of the particular protein ORF1ab in SARS-CoV-2.

Orf8 protein of SARS-CoV-2 doesn\'t contain a known useful motif or region. A total motif VLVVL (amino corrosive 75--79) has been found in SARS-CoV orf8b which was appeared to trigger intracellular stress pathways and enact NOD-like receptor family pyrin region containing-3 (NLRP3) ([@bb0100]). Moreover, multiple arrangements with different coronavirus ORF8 sequences propose that L84 related to 28144T\>C (L84S) isn\'t preserved ([@bb0050]). Thusly, it will be critical to examine the biological function of the particular protein (orf8) in SARS-CoV-2.

ORF10 is a short protein or peptide of length 38 deposits. Koyama et al. depicted that COVID-19 is ORF10 which doesn\'t have any comparative proteins in the NCBI repository. This one of a kind protein can be used to distinguish the infection more rapidly than PCR based strategies ([@bb0050]), but the further characterization of this protein is strongly required.

Another study demonstrated that NCBI had displayed new annotations for orf1ab as of late. NSP6 is the main contrast and it is considered as a putative protein ([@bb0050]). So, they held the NSP annotations. They further referenced that 12 remarkable variations in NSP3 protein in ORF1ab. Thus concluded that there was a basic connection between the nsp3 association and the inception of coronavirus infection ([@bb0035]). Besides, they investigated that NSP3 contains the papain-like protease and is regarded as significant for SARS infection ([@bb0075]). Variations found in subjects began from Wuhan are situated in either TM1 or Y space which is profoundly saved ([@bb0035], [@bb0040]).

Sawicki et al. performed sequencing of ORF1 from a huge available data that was established in labs ([@bb0095]). The report distinguished single point transformations coming from nonsynonymous substitutions in nsps 4, 5, 10, 12, 14 and 16. The collective outcomes recommend that the ORF1b nsp 12, 14 and 16 proteins characterize particular cistrons, while the distorted ORF1a proteins nsps 4, 5, and 10 form a compartment together at the location of the coding sequence of ORF1ab ([@bb0030]). Notably, of the eight announced mutations in MHV, seven of the influenced amino acid deposits are correlated with SARS-CoV ([@bb0030]). This methodology may permit the determination of phenotypic travelers that will distinguish by protein interactions. Also, it will permit the progressions to be acquainted in SARS-CoV with deciding whether the ts phenotype can be reproduced in that foundation, with the chance of quickly building up a board of SARS-CoV. Curiously, not only is the slow-growth branch dominated by travelers, but the COVID-19 lineages appear to be phylogenetically related to each other, suggesting an exposure point for these individuals that are distinct from the rest of the population.

5. Conclusion {#s0025}
=============

The fast increment of cases is giving more genomes that may give some visibility and proof of populace structure, especially of the chance of various presentations of COVID-19 into the human population. A comprehension of the biological reservoirs conveying these infections, and how the course to introduce has been carrying them into contact with human beings will be critical to comprehend future risks for novel diseases. This study showed how the disease spread among the travelers. This fight against COVID-19 will be a long one until we develop vaccines or effective treatments. However, we believe that collecting and sharing knowledge on variants will be effective. We should continue to be vigilant for the emergence of new variants or substrains and data should be gathered at one place for better understanding.
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